Gestational Diabetes: Diagnosis, Risks, and Management During Pregnancy

Table of Contents

Gestational diabetes is defined as glucose intolerance that begins or is first recognized during pregnancy. It typically appears in the second or third trimester.

Why GDM Occurs: Insulin Resistance

During pregnancy, the placenta produces hormones that are essential for the baby’s growth. Unfortunately, these same hormones can block the action of insulin in the mother’s cells—a process known as insulin resistance . When the mother’s pancreas cannot produce enough extra insulin to overcome this hormonal block, blood glucose levels rise, resulting in GDM.

Risk Factors for Developing GDM

While any pregnant woman can develop GDM, certain factors increase the likelihood:

  • Advanced maternal age (> 25 years old).

  • Obesity or having excess weight before pregnancy.

  • Family history of Type 2 diabetes.

  • Previous GDM diagnosis in an earlier pregnancy.

  • Having a baby previously weighing over 9 pounds (macrosomia).

  • Certain ethnicities (e.g., Hispanic, Black, Native American, Asian).

  • Having prediabetes or polycystic ovary syndrome (PCOS).

Screening, Diagnosis, and Goals of Care

Accurate screening for gestational diabetes is vital to prevent complications.

The Glucose Tolerance Test (OGTT)

Routine screening occurs between 24 and 28 weeks of pregnancy, though it may be earlier for high-risk individuals. The standard approach involves the one-step, 75-gram Oral Glucose Tolerance Test (OGTT) :

  1. Fasting: You must fast overnight (at least $\mathbf{8}$ hours) before the test.

  2. Baseline Test: A blood sample is taken for a fasting glucose measurement.

  3. Glucose Drink: You drink a 75-gram glucose solution.

  4. Timed Tests: Blood is drawn again at one hour and two hours after consuming the drink.

Diagnostic Thresholds (Table)

A diagnosis of GDM is confirmed if any single value from the 75-gram OGTT equals or exceeds the following plasma glucose thresholds:

Time Point

Blood Glucose Threshold (mg/dL)

Fasting

>92

1 Hour

>180

2 Hours

>153

Treatment Goals for Blood Glucose

Once diagnosed, the primary goal of care is to keep blood sugar levels within a tight, healthy range. The American Diabetes Association (ADA) recommends the following targets for tight control :

  • Fasting: < 95 mg/dL

  • 1-Hour Post-Meal: < 140 mg/dL

  • 2-Hour Post-Meal: < 120 mg/dL

Core Management Strategies

Management of gestational diabetes begins with lifestyle modifications.

Medical Nutrition Therapy (Diet)

The foundation of treatment is Medical Nutrition Therapy (MNT), ideally with a registered dietitian:

  • Carbohydrate Consistency: Distributing carbohydrate intake evenly throughout the day across small, frequent meals and snacks.

  • Quality Carbohydrates: Prioritize complex, high-fiber carbohydrates (whole grains, beans, non-starchy vegetables).

  • Balanced Meals: Pair carbohydrates with protein and healthy fats to slow glucose absorption.

Physical Activity

Regular physical activity is highly effective at improving insulin sensitivity.

  • Aim for 30 minutes of moderate-intensity exercise most days of the week, such as brisk walking.

  • Always consult your obstetrician before starting or changing your routine.

When Medication is Necessary (Insulin and Oral Agents)

If blood glucose targets are not met after one to two weeks of optimal diet and exercise, medication is required.

  • Insulin: Often the preferred medication because it is highly effective and does not cross the placenta, making it safe for the baby.

  • Oral Agents: Medications such as Metformin or Glyburide may be used in certain cases, but insulin remains the primary pharmacological choice.

Risks Associated with GDM

Uncontrolled gestational diabetes can increase risks for both mother and baby.

Maternal Complications (e.g., Preeclampsia)

  • Preeclampsia: Increased risk of this serious high blood pressure condition.

  • Cesarean Section: Due to the risk of the baby growing too large (macrosomia).

  • Future Type 2 Diabetes: Women with a history of GDM face a 7-fold higher risk of developing Type 2 diabetes later in life.

Fetal/Neonatal Complications (e.g., Macrosomia)

  • Macrosomia: Excessive fetal growth complicating delivery.

  • Neonatal Hypoglycemia: Dangerously low blood sugar in the baby after birth.

  • Future Health Risk: Children have a higher long-term risk of childhood obesity and developing Type 2 diabetes themselves.

Postpartum Care and Future Cardiovascular Risk Prevention

GDM is recognized as an independent, early risk factor for future cardiovascular disease (CVD).

The Crucial Postpartum Screening Test

You must undergo a 75-gram OGTT, which is mandatory 6–12 weeks postpartum.

Postpartum Test Result

Follow-up Plan

Normal Glucose Tolerance

Re-test at least every three years.

Prediabetes (Impaired Glucose Tolerance)

Annual testing; immediate and intensive lifestyle intervention.

Type 2 Diabetes

Immediate referral for long-term diabetes management.

Reducing Your Risk of Type 2 Diabetes and Heart Disease

  • Stay Active: Intensive lifestyle intervention (diet and exercise) can reduce your risk of developing Type 2 diabetes by over 50%.

  • Heart Monitoring: Routine screening of blood pressure, cholesterol, and other CVD markers is critical.

  • Breastfeeding: May help lower the mother’s and baby’s long-term diabetes risk.

Gestational diabetes is manageable. By committing to diet, exercise, and the mandatory 6–12 weeks postpartum OGTT, you seize a critical opportunity to protect your long-term health and reduce your risk of Type 2 diabetes and cardiovascular disease

References
  1. World Health Organization (WHO). Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Geneva: WHO; 2013.

  2. Centers for Disease Control and Prevention (CDC). Gestational Diabetes. Atlanta: CDC; 2023. Available from:https://www.cdc.gov/diabetes/about/gestational-diabetes.html

     

  3. American Diabetes Association (ADA). 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024. Diabetes Care. 2024;47(Suppl 1):S20-S41. Available from: https://diabetesjournals.org/care/article/47/Supplement_1/S20/153954/2-Diagnosis-and-Classification-of-Diabetes

     

  4. Colberg SR, Sigal RJ, et al. Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care. 2016;39(11):2065-2079. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6908414/

     

  5. Shah BR, et al. Gestational Diabetes Mellitus and the Incidence of Cardiovascular Disease. Diabetes Care. 2018;41(1):175-182. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8753767/

Frequently Asked Questions (FAQs)

Does gestational diabetes increase the risk of a C-section?

Yes. If not tightly controlled, GDM can lead to fetal macrosomia (a large baby), increasing the risk of birth complications and often necessitating a C-section.

How soon after birth should I have my blood sugar re-checked?

You must have a definitive diagnostic test, usually a two-hour 75-gram OGTT, at 6–12 weeks postpartum.

Can I breastfeed with gestational diabetes?

Yes, absolutely. Breastfeeding is strongly encouraged, as it may help the mother lose weight and reduce her long-term risk of developing Type 2 diabetes.

What is the long-term risk of heart disease after GDM?

GDM is an independent risk factor for future cardiovascular disease. The risk of developing CVD is up to two times higher than for women without GDM.

Recent Posts

Shopp Trusted Health Products

Top Posts

Take Charge of Your Heart Health Today!

Your well-being is our priority. If you have questions, need personalized advice, or want to learn more about heart health, we’re here to help.

Together, let’s protect what matters most—your health. 

Contact AORTA for heart health inquiries, educational support, or partnership opportunities. Our expert team is here to assist you.
Red heart icon with white aorta line and radiant rays — official symbol of AORTA.

Medically Reviewed & Expert-Led Content

This article was written and medically reviewed by qualified medical professionals with expertise in cardiovascular and related health conditions.

At AORTA, every piece of content is developed through a structured editorial process that prioritizes scientific accuracy, clinical relevance, and clarity for readers. Our medical experts base all information on trusted guidelines, peer-reviewed research, and established clinical evidence to ensure content you can rely on.

We are committed to maintaining the highest standards of integrity and transparency in health education.

Learn more about AORTA: